about
Adeno-associated virus (AAV) vectors in gene therapy: immune challenges and strategies to circumvent them.Bioengineering of AAV2 capsid at specific serine, threonine, or lysine residues improves its transduction efficiency in vitro and in vivo.Developing immunologically inert adeno-associated virus (AAV) vectors for gene therapy: possibilities and limitations.Synergistic inhibition of PARP-1 and NF-κB signaling downregulates immune response against recombinant AAV2 vectors during hepatic gene therapy.Carboxypeptidase E-∆N Promotes Proliferation and Invasion of Pancreatic Cancer Cells via Upregulation of CXCR2 Gene Expression
P50
description
investigador
@es
researcher
@en
name
Sangeetha Hareendran
@en
type
label
Sangeetha Hareendran
@en
prefLabel
Sangeetha Hareendran
@en
P31
P496
0000-0002-9070-8023